about
Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice.Functional mechanisms of the cellular prion protein (PrP(C)) associated anti-HIV-1 properties.Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.Whole body clonality analysis in an aggressive STLV-1 associated leukemia (ATLL) reveals an unexpected clonal complexity.Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes.Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles.Quantitative Analysis of Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection Using Co-Culture with Jurkat LTR-Luciferase or Jurkat LTR-GFP Reporter Cells.A dileucine motif targets MCAM-l cell adhesion molecule to the basolateral membrane in MDCK cells.Retrovirus infection strongly enhances scrapie infectivity release in cell culture.ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity.Correction: Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cellsTreatment of an aggressive STLV-1 associated lymphoma in a naturally infected baboon.Detection and quantification of STLV-1 and SFV proviral load in blood and saliva of naturally infected non-human primates.HTLV-1-infected HIS Rag2-/-γc-/- mice, a suitable model for in vivo investigating the effects of drugs in ATL treatment?Double-stranded RNA adenosine deaminase ADAR1 enhances both T cell susceptibility to human T-cell leukemia virus type 1 and 2 and viral replication.How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy.Comparative infection of autologous primary T cells and monocytes derived DCs using cell-free virus preparation, viral biofilm, pseudotyped-virus or viral synapse.Distinct DC subsets are not equally susceptible to HTLV-1 infection.STLV-1 co-infection is correlated with an increased SFV proviral load in the peripheral blood of SFV/STLV-1 naturally infected non-human primatesSensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation
P50
Q34147720-F0126985-1082-401B-ADD0-CF829906FCA2Q34231846-B6477150-6AEE-4FAF-ABF9-E1258A3566C1Q35714147-5E53E1BB-4CF8-44CB-BA95-69E1940FE18EQ36352268-DC74FB7B-209D-4FDB-979F-042A36A45A0FQ38844079-76CFC559-6AFB-4E7D-89BD-15AFDB208539Q38866973-F3A0986D-3FCE-4429-B4EF-4974A3BDB3FBQ39051969-D24CE05C-3085-4E1F-B826-E70DE9E41929Q39088537-C5152081-3CE9-4CBD-A388-ECAB1616481EQ39368038-85999293-22D3-4E1D-AD8A-E7D00884E19BQ39990786-1C4A2868-CA25-41FD-844D-1853E4EADCF5Q40267381-2A295731-9627-4D56-887D-7B6CE8127811Q40271006-FC326944-63AD-49CF-A439-1C94D51BC1ABQ41445328-0C347213-421F-4B93-B073-6B168F719F8DQ41666767-EB7FC88C-1B7F-4993-B2E8-B822A9F827B8Q42333111-6D1A0DCA-0A77-4EC7-82D0-C1A436997EBBQ46065928-A705508B-9509-45D4-BCB0-76AB25899E58Q46203980-D36F41F0-C132-443B-A04E-51C75A5ECA44Q47111123-1BB80DB9-FECC-4BE3-AFDD-260EF53DC729Q50319947-D7375BDD-D3FB-4521-AC27-10BE34008612Q54246489-F423AA33-BA02-4D5A-814C-776C4E3AE25BQ55448495-6BD0F653-61F5-4461-BC0B-EA4739CDF73CQ55541152-6BBA31CE-B864-409B-BA94-7AD8337CF474Q57061692-362AC3B9-AEB2-4265-8BC7-C22C2A17390BQ63707041-BAB79010-A6DD-4297-A5DA-D574E232D8B1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sandrine Alais
@ast
Sandrine Alais
@en
Sandrine Alais
@es
Sandrine Alais
@nl
type
label
Sandrine Alais
@ast
Sandrine Alais
@en
Sandrine Alais
@es
Sandrine Alais
@nl
prefLabel
Sandrine Alais
@ast
Sandrine Alais
@en
Sandrine Alais
@es
Sandrine Alais
@nl
P106
P21
P31
P496
0000-0001-9588-5435